hydralazine has been researched along with deuterium oxide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burney, IA; Field, SB; Griffiths, JR; Maxwell, RJ; McCoy, CL | 1 |
| Adams, GE; Bradley, JK; Bremner, JC; Counsell, CJ; Sansom, JM | 1 |
| Bentzen, L; Daugaard, P; Horsman, MR; Maxwell, RJ | 1 |
3 other study(ies) available for hydralazine and deuterium oxide
| Article | Year |
|---|---|
Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
Topics: Animals; Blood Pressure; Body Water; Calcitonin Gene-Related Peptide; Cell Hypoxia; Deuterium; Deuterium Oxide; Dose-Response Relationship, Drug; Fibrosarcoma; Hydralazine; Hyperthermia, Induced; Magnetic Resonance Spectroscopy; Prazosin; Rats; Rats, Inbred Strains; Regional Blood Flow; Time Factors | 1995 |
The accuracy and reproducibility of measuring blood flow in murine tumours by the D2O uptake and clearance techniques.
Topics: Animals; Deuterium Oxide; Hydralazine; Magnetic Resonance Spectroscopy; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Photochemotherapy; Regional Blood Flow; Reproducibility of Results | 1994 |
Non-invasive tumour blood perfusion measurement by 2H magnetic resonance.
Topics: Animals; Arteries; Deuterium Oxide; Disease Models, Animal; Female; Hydralazine; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Perfusion; Reproducibility of Results; Vasodilator Agents | 2000 |